Extendicare Inc. (EXETF)
USD 7.0
(-0.71%)
USD 7.0
(-0.71%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 111.78 Million CAD | 229.22% |
| 2022 | 20.98 Million CAD | -62.93% |
| 2021 | 56.61 Million CAD | -39.32% |
| 2020 | 93.3 Million CAD | 78.09% |
| 2019 | 52.39 Million CAD | 35.12% |
| 2018 | 38.77 Million CAD | -41.45% |
| 2017 | 66.21 Million CAD | 14.68% |
| 2016 | 57.74 Million CAD | 10.07% |
| 2015 | 52.46 Million CAD | 31.84% |
| 2014 | 39.79 Million CAD | -41.63% |
| 2013 | 68.17 Million CAD | -30.8% |
| 2012 | 98.51 Million CAD | -24.36% |
| 2011 | 130.24 Million CAD | -31.64% |
| 2010 | 190.54 Million CAD | -14.57% |
| 2009 | 223.04 Million CAD | 52.88% |
| 2008 | 145.89 Million CAD | -7.86% |
| 2007 | 158.34 Million CAD | -24.86% |
| 2006 | 210.73 Million CAD | 5.13% |
| 2005 | 200.45 Million CAD | 19.52% |
| 2004 | 167.71 Million CAD | 36.17% |
| 2003 | 123.17 Million CAD | -33.23% |
| 2002 | 184.46 Million CAD | 18.73% |
| 2001 | 155.35 Million CAD | 25.88% |
| 2000 | 123.41 Million CAD | -13.74% |
| 1999 | 143.07 Million CAD | -43.47% |
| 1998 | 253.08 Million CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 30.35 Million CAD | 78.89% |
| 2024 Q1 | 21.58 Million CAD | 101.12% |
| 2023 Q1 | 25.09 Million CAD | 12162.5% |
| 2023 Q4 | 10.73 Million CAD | -53.78% |
| 2023 FY | 69.09 Million CAD | 229.22% |
| 2023 Q3 | 23.22 Million CAD | 169.03% |
| 2023 Q2 | 8.63 Million CAD | -65.6% |
| 2022 Q1 | 11.28 Million CAD | -44.02% |
| 2022 Q4 | -208 Thousand CAD | -175.64% |
| 2022 Q2 | 9.63 Million CAD | -14.64% |
| 2022 Q3 | 275 Thousand CAD | -97.15% |
| 2022 FY | 20.98 Million CAD | -62.93% |
| 2021 Q1 | 18.06 Million CAD | -37.61% |
| 2021 FY | 56.61 Million CAD | -39.32% |
| 2021 Q2 | 8.64 Million CAD | -52.18% |
| 2021 Q4 | 20.16 Million CAD | 106.75% |
| 2021 Q3 | 9.75 Million CAD | 12.86% |
| 2020 Q3 | 54.64 Million CAD | 4634.77% |
| 2020 Q4 | 28.95 Million CAD | -47.01% |
| 2020 Q2 | -1.2 Million CAD | -111.29% |
| 2020 Q1 | 10.67 Million CAD | -17.98% |
| 2020 FY | 93.3 Million CAD | 78.09% |
| 2019 Q2 | 14.29 Million CAD | 64.36% |
| 2019 Q1 | 8.69 Million CAD | 302.8% |
| 2019 Q4 | 13.01 Million CAD | -5.21% |
| 2019 FY | 52.39 Million CAD | 35.12% |
| 2019 Q3 | 13.72 Million CAD | -3.96% |
| 2018 Q1 | 11.96 Million CAD | -38.3% |
| 2018 FY | 38.77 Million CAD | -41.45% |
| 2018 Q2 | 15.72 Million CAD | 31.45% |
| 2018 Q3 | 15.37 Million CAD | -2.18% |
| 2018 Q4 | -4.28 Million CAD | -127.88% |
| 2017 Q4 | 19.38 Million CAD | 19.23% |
| 2017 Q1 | 13.89 Million CAD | -1.29% |
| 2017 Q2 | 16.67 Million CAD | 20.0% |
| 2017 FY | 66.21 Million CAD | 14.68% |
| 2017 Q3 | 16.25 Million CAD | -2.51% |
| 2016 FY | 57.74 Million CAD | 10.07% |
| 2016 Q4 | 14.07 Million CAD | -20.65% |
| 2016 Q2 | 18.68 Million CAD | 195.85% |
| 2016 Q3 | 17.74 Million CAD | -5.07% |
| 2016 Q1 | 6.31 Million CAD | -47.21% |
| 2015 FY | 52.46 Million CAD | 31.84% |
| 2015 Q4 | 11.96 Million CAD | -26.04% |
| 2015 Q2 | 14.89 Million CAD | 58.19% |
| 2015 Q1 | 9.41 Million CAD | -62.78% |
| 2015 Q3 | 16.17 Million CAD | 8.59% |
| 2014 FY | 39.79 Million CAD | -41.63% |
| 2014 Q4 | 25.3 Million CAD | 83.36% |
| 2014 Q3 | 13.8 Million CAD | 193.91% |
| 2014 Q2 | -14.69 Million CAD | -195.53% |
| 2014 Q1 | 15.38 Million CAD | 297.57% |
| 2013 Q3 | 22.88 Million CAD | 7.27% |
| 2013 FY | 68.17 Million CAD | -30.8% |
| 2013 Q4 | 3.86 Million CAD | -83.09% |
| 2013 Q2 | 21.33 Million CAD | 6.21% |
| 2013 Q1 | 20.08 Million CAD | -41.47% |
| 2012 Q4 | 34.31 Million CAD | 155.07% |
| 2012 Q2 | 21.37 Million CAD | -27.25% |
| 2012 FY | 98.51 Million CAD | -24.36% |
| 2012 Q1 | 29.37 Million CAD | 445.86% |
| 2012 Q3 | 13.45 Million CAD | -37.05% |
| 2011 Q3 | 41.86 Million CAD | -11.52% |
| 2011 Q2 | 47.3 Million CAD | 119.18% |
| 2011 FY | 130.24 Million CAD | -31.64% |
| 2011 Q4 | 5.38 Million CAD | -87.14% |
| 2011 Q1 | 21.58 Million CAD | -62.95% |
| 2010 Q4 | 58.25 Million CAD | 51.05% |
| 2010 Q1 | 47.8 Million CAD | 2.74% |
| 2010 FY | 190.54 Million CAD | -14.57% |
| 2010 Q2 | 45.91 Million CAD | -3.95% |
| 2010 Q3 | 38.56 Million CAD | -16.01% |
| 2009 FY | 223.04 Million CAD | 52.88% |
| 2009 Q1 | 43.05 Million CAD | -5.04% |
| 2009 Q2 | 67.48 Million CAD | 56.72% |
| 2009 Q3 | 71.09 Million CAD | 5.36% |
| 2009 Q4 | 46.53 Million CAD | -34.55% |
| 2008 Q1 | 36.23 Million CAD | 12888.17% |
| 2008 FY | 145.89 Million CAD | -7.86% |
| 2008 Q4 | 45.34 Million CAD | 23.32% |
| 2008 Q3 | 36.77 Million CAD | 18.42% |
| 2008 Q2 | 31.05 Million CAD | -14.31% |
| 2007 FY | 158.34 Million CAD | -24.86% |
| 2007 Q3 | 382.61 Million CAD | 608.12% |
| 2007 Q4 | 279 Thousand CAD | -99.93% |
| 2007 Q2 | 54.03 Million CAD | 2.66% |
| 2007 Q1 | 52.63 Million CAD | 223.48% |
| 2006 Q2 | 40.7 Million CAD | 8.13% |
| 2006 Q4 | -42.62 Million CAD | -252.46% |
| 2006 Q1 | 37.64 Million CAD | -44.07% |
| 2006 Q3 | 27.95 Million CAD | -31.32% |
| 2006 FY | 210.73 Million CAD | 5.13% |
| 2005 Q2 | 87.79 Million CAD | 33.3% |
| 2005 Q1 | 65.86 Million CAD | 17.79% |
| 2005 FY | 200.45 Million CAD | 19.52% |
| 2005 Q3 | 50.02 Million CAD | -43.02% |
| 2005 Q4 | 67.3 Million CAD | 34.56% |
| 2004 Q1 | 55.11 Million CAD | 0.61% |
| 2004 Q4 | 55.91 Million CAD | 15.47% |
| 2004 Q3 | 48.42 Million CAD | -23.45% |
| 2004 FY | 167.71 Million CAD | 36.17% |
| 2004 Q2 | 63.25 Million CAD | 14.78% |
| 2003 Q1 | 23.09 Million CAD | 0.0% |
| 2003 FY | 123.17 Million CAD | -33.23% |
| 2003 Q3 | 55.52 Million CAD | 81.31% |
| 2003 Q4 | 54.77 Million CAD | -1.34% |
| 2003 Q2 | 30.62 Million CAD | 32.59% |
| 2002 FY | 184.46 Million CAD | 18.73% |
| 2001 FY | 155.35 Million CAD | 25.88% |
| 2000 FY | 123.41 Million CAD | -13.74% |
| 1999 FY | 143.07 Million CAD | -43.47% |
| 1998 FY | 253.08 Million CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| The Amacore Group, Inc. | -25.84 Million USD | 532.597% |
| Arem Pacific Corporation | -23.6 Thousand USD | 473753.659% |
| Assisted 4 Living, Inc. | -121.58 Thousand USD | 92044.465% |
| BioCorRx Inc. | -3.78 Million USD | 3051.241% |
| Bionik Laboratories Corp. | -4.82 Million USD | 2416.81% |
| Banyan Corp. | -1.59 Million USD | 7113.505% |
| Clearday, Inc. | -11.85 Million USD | 1043.166% |
| Dental Patient Care America, Inc. | -31.55 Thousand USD | 354338.362% |
| Quantum Medical Transport, Inc. | 222.84 USD | -50164592.156% |
| Empower Clinics Inc. | -4.95 Million USD | 2356.357% |
| First Choice Healthcare Solutions, Inc. | -2.41 Million USD | 4737.637% |
| Selectis Health, Inc. | -8.96 Million USD | 1347.564% |
| Ethema Health Corporation | -541.92 Thousand USD | 20727.952% |
| HealthLynked Corp. | -3.83 Million USD | 3017.388% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | -2.65 Million USD | 4311.405% |
| JRSIS Health Care Corporation | -188.59 Thousand USD | 59372.633% |
| Comjoyful International Company | - USD | -Infinity% |
| Medical Facilities Corporation | 67.1 Million USD | -66.575% |
| MedSmart Group Inc. | -84.51 Thousand USD | 132376.654% |
| North America Frac Sand, Inc. | -702.5 Thousand USD | 16012.74% |
| Nova Leap Health Corp. | 460.15 Thousand USD | -24193.494% |
| Nexteligent Holdings, Inc. | -201.72 Thousand USD | 55515.266% |
| PAO Group, Inc. | -45.42 Thousand USD | 246218.45% |
| Primemd Inc. | 4.15 Million USD | -2587.991% |
| Raffles Medical Group Ltd | 87.71 Million USD | -27.442% |
| Ryman Healthcare Limited | -26.98 Million USD | 514.22% |
| Stem Cell Authority, Ltd. | -4230.00 USD | 2642818.676% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | -2.25 Million USD | 5066.572% |
| Mycotopia Therapies, Inc. | -616.72 Thousand USD | 18225.936% |
| U.S. NeuroSurgical Holdings, Inc. | -765 Thousand USD | 14712.68% |
| Veltex Corporation | -1.08 Million USD | 10426.505% |
| World Financial Holding Group | -28.43 Thousand USD | 393300.844% |
| Xcelerate Inc. | -2.61 Million USD | 4378.656% |